Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002266174 | SCV002547716 | uncertain significance | not specified | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003698892 | SCV004462010 | likely benign | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004612167 | SCV005111090 | uncertain significance | Inborn genetic diseases | 2024-03-18 | criteria provided, single submitter | clinical testing | The c.5747C>T (p.T1916I) alteration is located in exon 38 (coding exon 38) of the ABCA12 gene. This alteration results from a C to T substitution at nucleotide position 5747, causing the threonine (T) at amino acid position 1916 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |